Drug Metabolism Letters
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 4
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
Li P. Albert, Meet Our Editorial Board Member, Drug Metabolism Letters 2016; 10 (4) . https://dx.doi.org/10.2174/187231281004170315182757
DOI https://dx.doi.org/10.2174/187231281004170315182757 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
14
Related Articles
-
Persian Herbal Medicine in Functional Dyspepsia: A Systematic Review
Current Drug Discovery Technologies Cannabis Use and Psychosis: Theme Introduction
Current Pharmaceutical Design Vitamin D Supplementation in Diabetic Foot Ulcers: A Current Perspective
Current Diabetes Reviews 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data
Inflammation & Allergy - Drug Targets (Discontinued) Ansamycin Inhibitors of Hsp90: Natures Prototype for Anti-Chaperone Therapy
Current Topics in Medicinal Chemistry Preface
Current Pharmaceutical Design Phospholipase D Inhibition: Beneficial and Harmful Consequences for a Double-Dealer Enzyme
Current Enzyme Inhibition Anti-adipogenic and Cytotoxic Effects of a New Compound from <i>Hartmannia rosea</i> G. Don
Current Pharmaceutical Analysis Tetraplex Binding Molecules as Anti-Cancer Agents
Recent Patents on Anti-Cancer Drug Discovery An Insight into Oligopeptide Transporter 3 (OPT3) Family Proteins
Protein & Peptide Letters The Molecular Functions of Nod Proteins and their Associated Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploring the Potential of NO-Independent Stimulators and Activators of Soluble Guanylate Cyclase for the Medical Treatment of Erectile Dysfunction
Current Pharmaceutical Design HIV-1 Capsid Inhibitors as Antiretroviral Agents
Current HIV Research Editorial: [A Threat to One is a Threat to All – Biosecurity for the Western World Starts in Developing Countries: Do We Speak the Same Language of Hygiene?]
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Mechanisms of Inflammation. Anti-Inflammatory Benefits of Virgin Olive Oil and the Phenolic Compound Oleocanthal
Current Pharmaceutical Design Targeting Antibody-Mediated Rejection in the Setting of ABOIncompatible Infant Heart Transplantation: Graft Accommodation vs. B Cell Tolerance
Current Drug Targets - Cardiovascular & Hematological Disorders The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
Current Neuropharmacology Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets